30 countries, including South Africa, launch alliance to share Covid-19 tools

Thirty countries including South Africa have launched have an initiative aimed at sharing vaccines, medicines and diagnostic tools to tackle the global coronavirus pandemic. Picture: Simphiwe Mbokazi African NewsAgency

Thirty countries including South Africa have launched have an initiative aimed at sharing vaccines, medicines and diagnostic tools to tackle the global coronavirus pandemic. Picture: Simphiwe Mbokazi African NewsAgency

Published May 29, 2020

Share

Zurich - Thirty countries led by Costa

Rica and the World Health Organization launched an initiative on

Friday aimed at sharing vaccines, medicines and diagnostic tools

to tackle the global coronavirus pandemic.

Countries to sign up are South Africa, Argentina, Bangladesh, Barbados, Belize, Brazil, Chile, Dominican Republic, Ecuador, Egypt, Indonesia, Lebanon, Luxembourg, Malaysia, Maldives, Mexico, Mozambique, Norway, Oman, Pakistan, Palau, Panama, Peru, Portugal, Saint Vincent and the Grenadines, Sudan, the Netherlands, East Timor and Uruguay, the WHO said.

While the developing nations' push, called the Covid-19

Technology Access Pool, was welcomed by groups including Doctors

Without Borders, a drug industry alliance questioned if it would

really boost collaboration or broaden access to Covid-19

medicines.

The WHO effort comes amid concerns rich countries pumping

resources into finding vaccines - more than 100 are in

development - will muscle their way to the front of the queue,

once a candidate succeeds.

Switzerland, home of big drugmakers Roche and

Novartis, has also raised fears of "vaccine

nationalism", saying it wants to ensure fair access.

"Vaccines, tests, diagnostics, treatments and other key

tools in the coronavirus response must be made universally

available as global public goods," Costa Rica President Carlos

Alvarado said, of the voluntary initiative.

The effort, originally proposed in March, aims to provide a

one-stop shop for scientific knowledge, data and intellectual

property amid a pandemic that has infected more than 5.8 million

people and killed some 360,000.

The WHO issued a "Solidarity Call to Action", asking other

stakeholders to join the push.

However, the International Federation of Pharmaceutical

Manufacturers & Associations raised concerns about undermining

intellectual property protections, which the industry group said

enable collaboration and will be needed after the pandemic is

over, to prepare health systems for new challenges.

"By urging licences or non-enforcement declarations for

Covid-19 treatments and vaccines to be granted on a

non-exclusive global basis, the 'Solidarity Call to Action'

promotes a one-size-fits all model that disregards the specific

circumstances of each situation, each product and each country,"

the federation said.

Related Topics:

#coronavirus